Introduction —
This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of lymphoma (2025)
●Measurable residual disease in chronic lymphocytic leukemia – Expert review and consensus recommendations (2021)
●International Lymphoma Radiation Oncology Group (ILROG): An overview of guidelines for involved site radiation therapy in adult lymphomas (2020)
●ILROG: Guidelines for the optimal use of imaging in radiation therapy for lymphoma (2019)
●International Workshop on Chronic Lymphocytic Leukemia (iwCLL): Guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL (2018)
Canada
●Choosing Wisely Canada: Don't request a fine-needle aspirate (FNA) for the evaluation of suspected lymphoma (2023)
●Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia (2018)
●Cancer Care Ontario (CCO): The clinical utility of positron emission tomography in the diagnosis, staging, and clinical management of patients with lymphoma – Recommendation report (2015)
United States
●American Society for Blood and Marrow Transplantation (ASBMT): Clinical practice recommendations for use of allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia (2016)
Europe
●European Research Initiative on CLL (ERIC): Recommendations for TP53 mutation analysis in chronic lymphocytic leukemia, update (2024)
●ERIC: Recommendations on how to report the results from immunoglobulin heavy variable gene analysis in chronic lymphocytic leukemia, updates (2024)
•ERIC: Recommendations on immunoglobulin gene sequence analysis in chronic lymphocytic leukemia, update (2022)
●European Society for Medical Oncology (ESMO): Clinical practice guideline on new targeted therapies in the first-line and at relapse of chronic lymphocytic leukaemia, interim update (2024)
•ESMO: Clinical practice guidelines for diagnosis, treatment, and follow-up of chronic lymphocytic leukaemia (2021)
●ERIC: Perspectives and recommendations for cytogenetics in chronic lymphocytic leukemia (2022)
●ESMO: Consensus conference on malignant lymphoma – General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma (2018)
●ESMO: Consensus conference on malignant lymphoma – General perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia (2016)
United Kingdom
●British Society for Haematology (BSH): Guideline for the treatment of chronic lymphocytic leukaemia (2022)
●BSH: Good practice paper for the management of cardiovascular complications of bruton tyrosine kinase inhibitors (2021)
●BSH: Good practice paper on Richter transformation of chronic lymphocytic leukaemia (2021)
Australia–New Zealand
●Choosing Wisely Australia: Do not perform baseline or routine surveillance CT scans or bone marrow biopsy in patients with asymptomatic early stage chronic lymphocytic leukaemia (CLL) (2015)
